Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Lab Bench Meets Federal Bench: The Supreme Court and Stem Cell Research

February 15, 2013

Lab Bench Meets Federal Bench: The Supreme Court and Stem Cell Research
The Supreme Court recently refused to hear a case challenging federal funding for embryonic stem cell research. Dr. John Murray, a lawyer and geneticist, and Dr. Chris Henderson, scientific director of Target ALS, discuss the case and the field of stem cell research.

The Supreme Court recently refused to hear a case challenging federal funding for embryonic stem cell research. Experts discuss the case and its consequences, as well as exciting research being done with stem cells towards a treatment for Lou Gehrig's disease.